Cellply

Developer of in-vitro diagnostic products for the detection of cancer

placeBologna, Emilia Romagna, Italy calendar_todayFounded 2013 groups28 employees language cellply.com

Social engagement

Social engagement: 9.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

17 investors on record; lead investors include LIFTT, Rearden, Metaventures, Indaco Venture Partners.

Investor typeCountShare
Venture capital847%
Private equity212%
Angel & family office16%
Accelerator & incubator212%
Other / undisclosed424%

Recent activity

18 Jun 2026
Partnership
NextGenNK Competence Center at Karolinska Institutet
15 Jun 2026
Event
REPRESSIT or NOT: What is the future of immune checkpoint inhibitors?
22 Apr 2026
Product launch
VivaCyte®
Coming soon